810132C

18:1-06:0 NBD PC

Avanti Research^™ - A Croda Brand 810132C

• Synonym(e): 1-oleoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphocholine
• Empirische Formel (Hill-System): C₃₈H₆₄N₅O₁₁P
• CAS-Nummer: 106974-05-4
• Molekulargewicht: 797.92
• UNSPSC-Code: 12352211
• NACRES: NA.25

Eigenschaften

• Assay: >99% (TLC)
• Form: liquid
• Verpackung: pkg of 1 × 1 mL (810132C-1mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 810132C
• Konzentration: 1 mg/mL (810132C-1mg)
• Versandbedingung: dry ice
• Lagertemp.: −20°C

Beschreibung

Allgemeine Beschreibung

Phosphocholine is considered as a precursor molecule. It is formed during the breakdown of phosphatidylcholine (PC) metabolism. 18:1-06:0 NBD PC is a fluorescent lipid analog/probe.

Anwendung

18:1-06:0 NBD PC is suitable for use:

• as a component in preparing lipid solution for bilayer formation
• to use as a single donor in fluorescence resonance energy transfer (FRET) based assay
• to prepare phospholipid-coated beads

Biochem./physiol. Wirkung

NBD‐PC can be used to probe the existence of (Rho‐labeled) protease‐activated receptor (PAR) pepducins in the outer and inner leaflets.

Verpackung

5 mL Amber Glass Screw Cap Vial (810132C-1mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Piktogramme: GHS06,GHS08
• Signalwort: Danger
• H-Sätze: H302,H315,H319,H331,H336,H351,H361d,H372
• P-Sätze: P201 - P260 - P264 - P280 - P304 + P340 + P311 - P403 + P233
• Gefahreneinstufungen: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• Zielorgane: Central nervous system
• WGK: WGK 3